All posts
-
Amazon’s stock falls after it ups its fiscal 2026 spending forecast to $200B
Amazon.com Inc. supplied record quarterly earnings on the back of solid cloud development throughout the 4th quarter, however its supply dropped in late trading after it missed out…
-
Fundamental launches with $255M and an AI model optimized for tabular data
Expert system start-up Basic Technologies Inc. introduced today with $255 million in first financing from a team of popular financiers. The firm increased the mass of the funding v…
-
Cybersecurity earnings season kicks off with beats from Fortinet, NetScout and Qualys
Cybersecurity firms Fortinet Inc., NetScout Equipments Inc. and Qualys Inc. all reported profits and earnings beats in their newest quarterly records today as need for cybersecurit…
-
Five thoughts – plus a comment on the importance of leadership – from Cisco’s 2026 AI Summit
Cisco Equipments Inc. held its 2nd yearly AI Top today, with a star-studded schedule of expert system celebs. Unlike many supplier occasions, the Cisco AI Top was made to be a R…
-
OpenAI introduces Frontier agent management platform and new GPT-5.3-Codex model
OpenAI Team PBC today presented a system called Frontier that firms can make use of to develop and handle expert system representatives. The offering debuted together with a brand-…
-
From backup to ResOps: How Commvault is reframing cyber resilience
The durability discussion has actually relocated from framework groups to the exec schedule– due to the fact that when identification and information can not be relied on, up…
-
Process intelligence moves enterprise AI from PoC to ROI
As enterprise AI initiatives move from experimentation to scrutiny, many organizations are confronting a familiar gap between promise and payoff. Early pilots have demonstrated tec…
-
Hims and Hers turns negative after threat from Novo Nordisk
After Novo Nordisk provided a caution on Thursday regarding lawsuits versus Hims and Hers’ duplicate tablet, the supply has actually gone down considerably.
-
Doustdar doubts effect of copy pill: “Waste of 49 dollars”
Mike Doustdar questions Hims and Hers’ duplicate of the fat burning tablet Wegovy, which is currently on the marketplace.
-
Novo Nordisk takes legal action against Hims and Hers
A couple of hours after the American business revealed an inexpensive duplicate of Novo Nordisk’s weight management tablet, the Danish business strikes back.
